source
- Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator leadAbbott has received both FDA and CE Mark approval for its UltiSynq defibrillation lead tech, which is designed to deliver both conduction system pacing and defibrillation therapy.
- Opinion: Low-income parents can’t afford to take chances with nutritious food their picky eaters might reject“Children's food refusals come at a cost — one that few cash-strapped families can afford,” experts write.STAT · 48m ago↗ source